Already at best price
Myovite M Tablet SR
Metformin (500mg) + Myo-Inositol (600mg)
Astraea Life Sciences Pvt Ltd
Anti-Diabetic
₹189.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹189.00
Active composition
Metformin 500 mg
+1 more active ingredient
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
500 mg
All Active Ingredients
Metformin500 mg
Myo-Inositol600 mg
Uses & Benefits
Medical applications
Diabetes
Myovite M Tablet SR is a unique, extended-release formulation that combines Metformin (500mg) and Myo-Inositol (600mg) in a single tablet. Metformin, a biguanide, is a widely recognized antihyperglycemic agent, primarily used in the management of Type 2 Diabetes Mellitus. Myo-Inositol, an essential nutrient, has been shown to have synergistic effects with Metformin, potentially enhancing insulin sensitivity, improving ovulation, and reducing oxidative stress. This synergistic combination may provide enhanced glycemic control, improved metabolic profile, and potential benefits for polycystic ovary syndrome (PCOS) management, making Myovite M Tablet SR a promising therapeutic option for diabetes and related metabolic disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Myovite M Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Myovite M Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Myovite M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Myovite M Tablet SR may be needed. Please consult your doctor. Use of Myovite M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Myovite M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Myovite M Tablet SR may be needed. Please consult your doctor. Myovite M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Myovite M Tablet SR
Myovite M Tablet SR
1 / 2
Myovite M Tablet SR
Metformin (500mg) + Myo-Inositol (600mg)
₹189.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metformin 500 mg
+1 more active ingredient
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
500 mg
All Active Ingredients
Metformin500 mg
Myo-Inositol600 mg
Uses & Benefits
Medical applications
Diabetes
Myovite M Tablet SR is a unique, extended-release formulation that combines Metformin (500mg) and Myo-Inositol (600mg) in a single tablet. Metformin, a biguanide, is a widely recognized antihyperglycemic agent, primarily used in the management of Type 2 Diabetes Mellitus. Myo-Inositol, an essential nutrient, has been shown to have synergistic effects with Metformin, potentially enhancing insulin sensitivity, improving ovulation, and reducing oxidative stress. This synergistic combination may provide enhanced glycemic control, improved metabolic profile, and potential benefits for polycystic ovary syndrome (PCOS) management, making Myovite M Tablet SR a promising therapeutic option for diabetes and related metabolic disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Myovite M Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Myovite M Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Myovite M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Myovite M Tablet SR may be needed. Please consult your doctor. Use of Myovite M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Myovite M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Myovite M Tablet SR may be needed. Please consult your doctor. Myovite M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Myovite M Tablet SR
%22%2F%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22158%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%20font-size%3D%2244%22%20font-weight%3D%22800%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.45%22%20transform%3D%22rotate(-16%20150%20158)%22%3EDrugIndia%3C%2Ftext%3E%0A%3Cg%20fill%3D%22%23fb7185%22%20opacity%3D%220.5%22%3E%3Cpath%20d%3D%22M44%2048h6v6h6v6h-6v6h-6v-6h-6v-6h6z%22%2F%3E%3Cpath%20d%3D%22M250%20214h5v5h5v5h-5v5h-5v-5h-5v-5h5z%22%2F%3E%3C%2Fg%3E%0A%3Cellipse%20cx%3D%22150%22%20cy%3D%22120%22%20rx%3D%22118%22%20ry%3D%2286%22%20fill%3D%22url(%23glow)%22%2F%3E%0A%3Cg%20transform%3D%22rotate(-28%20150%20120)%22%20filter%3D%22url(%23soft)%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Crect%20x%3D%2289%22%20y%3D%2297%22%20width%3D%22122%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22url(%23cap)%22%2F%3E%0A%3Cpath%20d%3D%22M89%20120a23%2023%200%200%201%2023-23h38v46h-38a23%2023%200%200%201-23-23z%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.16%22%2F%3E%0A%3Cline%20x1%3D%22150%22%20y1%3D%2298%22%20x2%3D%22150%22%20y2%3D%22142%22%20stroke%3D%22%23ffffff%22%20stroke-width%3D%222%22%20opacity%3D%220.55%22%2F%3E%0A%3Cellipse%20cx%3D%22118%22%20cy%3D%22110%22%20rx%3D%2215%22%20ry%3D%225%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.4%22%2F%3E%0A%3C%2Fg%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22206%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3ESITARAY%20M%3C%2Ftext%3E%3Ctext%20x%3D%22150%22%20y%3D%22232%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3E50%2F500MG%20TAB%3C%2Ftext%3E%0A%3Cg%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22271%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.85%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22270%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23c2410c%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E)